The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8188228 B1

PDF
Full Text
Expired
Date of Patent:
May. 29, 2012

Filed:

Apr. 20, 2010
Applicants:

Arthur B. Raitano, Los Angeles, CA (US);

Pia M. Challita-eid, Encino, CA (US);

Mary Faris, Los Angeles, CA (US);

Rene S. Hubert, Los Angeles, CA (US);

Wangmao GE, Tampa, FL (US);

Aya Jakobovits, Beverly Hills, CA (US);

Inventors:

Arthur B. Raitano, Los Angeles, CA (US);

Pia M. Challita-Eid, Encino, CA (US);

Mary Faris, Los Angeles, CA (US);

Rene S. Hubert, Los Angeles, CA (US);

Wangmao Ge, Tampa, FL (US);

Aya Jakobovits, Beverly Hills, CA (US);

Assignee:

Agensys, Inc., Santa Monica, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 5/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel gene 0193P1E1B (also designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 193P1E1B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 193P1E1B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 193P1E1B can be used in active or passive immunization.


Find Patent Forward Citations

Loading…